Overweight and Obesity in Children. Other obesity
Conditions
Interventions
Intervention 1: Intervention group: Students in the intervention group are members of the Eitaa group (Eitaa: an Iranian messaging app that supports multimedia content and provides useful nutrition ti
Sponsors
Oroumia University of Medical Sciences
Eligibility
Sex/Gender
All
Age
9 Years to 12 Years
Inclusion criteria
Inclusion criteria: Children aged 9 to 12 years Proficient in Persian (due to the study settings and program language) Overweight (BMI percentile > 85 and = 95) and obese (BMI percentile > 95) Possessing a mobile phone
Exclusion criteria
Exclusion criteria: Secondary causes of obesity (such as endocrine disorders, including hypothyroidism and type 2 diabetes) Chronic diseases, such as cardiovascular diseases, kidney diseases, liver diseases, obstructive lung diseases, and classic symptoms of hyperglycemia (polyuria, polydipsia, polyphagia, and weight loss) Severe acute illnesses; children undergoing chemotherapy Patients undergoing pharmacological interventions for weight loss, children who have previously participated in weight loss programs, or those currently using a lifestyle modification program Concurrent participation in another study or having participated in another clinical trial in the past 12 months Patients who have undergone any form of metabolic surgery Obstructive sleep apnea Genetic syndromes Neurodevelopmental disorders and mental health disorders Long-term use of medications Neurological or physical disabilities (e.g., Down syndrome, paralysis; limbs affected) Intake of dietary supplements (such as zinc and vitamin D) Children who are on a diet
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary Outcomes: Anthropometric Indices (BMI Z-Score). Timepoint: The intervention will be conducted over a period of six months, divided into three time points: the onset of the study (T0), three months (during the intervention), and six months (post-intervention). Method of measurement: Primary outcomes by measuring anthropometric indicators and during three time periods; Start of study, 3 months and 6 months (end of intervention). | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary Outcomes: Systolic Blood Pressure (SBP). Timepoint: The intervention will be conducted over a period of six months, divided into three time points: the onset of the study (T0), three months (during the intervention), and six months (post-intervention). Method of measurement: Secondary outcomes involve measuring systolic and diastolic blood pressure using the Brisk blood pressure monitor (Model: TY-A02) at three time points: the start of the study, 3 months, and 6 months (end of the intervention). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAzadeh Saeedikia
Oroumia University of Medical Sciences
Outcome results
None listed